Drugs / rVWF
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03879135 | Apr 2019 → Jan 2025 | von Willebrand disease (hereditary or acquired) | Baxalta now part of Shire | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rVWF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03879135 ↗ |
| Modality | Protein / enzyme biologic | “recombinant von Willebrand factor” NCT03879135 ↗ |